Market cap
$13 Mln
Revenue (TTM)
$15 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -94.08 | -33.31 | -12.25 | -- |
| EBIT | 6.28 | 23.97 | 6.86 | -49.68 | -- |
| Net Profit | 2.04 | 23.67 | 66.89 | 10.22 | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -293.54 | -- | -472.99 | -383.68 | -253.78 |
| Net Margin
| -242.66 | -- | -162.13 | -- | -253.28 |
| Return on equity
| -109.09 | -- | -62.64 | -86.40 | -54.71 |
| Return on Capital
| -54.47 | -- | -- | -56.23 | -37.34 |
| Return on Assets
| -34.70 | -- | -18.74 | -47.99 | -30.05 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.48 | 0.56 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
--
|
-56.23
|
-37.34
|
-69.84
|
86.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-62.64
Lower than Peers by 22.24
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-62.64
|
-86.40
|
-54.71
|
-186.17
|
55.01
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-18.74
Higher than Peers by 12.24
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-18.74
|
-47.99
|
-30.05
|
-26.06
|
-24.04
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-472.99
Lower than Peers by 389.37
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-472.99
|
-383.68
|
-253.78
|
-243.16
|
-177.37
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-162.13
Lower than Peers by 69.46
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-162.13
|
-372.08
|
-253.28
|
-232.05
|
-166.66
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-33.31
Lower than Peers by 87.27
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-33.31
|
-0.22
|
0.29
|
0.09
|
0.52
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
6.86
Higher than Peers by 7.66
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
6.86
|
-17.33
|
-34.69
|
-49.01
|
-78.55
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
66.89
Higher than Peers by 74.19
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
66.89
|
-13.88
|
-37.49
|
-55.21
|
-67.25
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
--
|
0.48
|
0.56
|
0.37
|
-0.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.11
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
0.11
|
0.11
|
0.08
|
0.06
|
-0.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.79
Lower than Peers by 3.02
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
2.79
|
3.12
|
4.53
|
3.91
|
2.66
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
2.79
Lower than Peers by 2.90
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
2.79
|
3.14
|
4.54
|
3.92
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-58.17
Lower than Peers by 56.08
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-58.17
|
-8.30
|
-2,456.04
|
--
|
--
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
--
|
1.83
|
11.42
|
11.63
|
10.79
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.11
Higher than Peers by 0.05
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
0.11
|
0.13
|
0.12
|
0.11
|
0.14
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
--
|
30.21
|
37.32
|
39.36
|
31.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.50
Lower than Peers by 4.68
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
0.50
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.18
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
-0.18
|
0.61
|
1.28
|
3.07
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
13
Lower than Peers by 133
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Sqz Biotechnologies Co (SQZ)
|
13
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|